Opportunity Information: Apply for PAR 11 152
Apply for PAR 11 152
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213 Research and Training in Complementary and Integrative Health 93.393 Cancer Cause and Prevention Research 93.396 Cancer Biology Research.
- This funding opportunity was created on Mar 15, 2011 and posted on Mar 15, 2011.
- Applicants must submit their applications by Nov 15, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: For profit organizations other than small businesses Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public and State controlled institutions of higher education State governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Foreign (non U.S.) components on applications submitted by U.S. Organizations are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The funding opportunity "The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01)" (PAR-11-152) is a National Institutes of Health cooperative agreement led by the National Cancer Institute (NCI) in partnership with the National Center for Complementary and Alternative Medicine (NCCAM). It focuses on how gut (and other) microbes transform dietary components into metabolites, and how those microbially produced compounds then influence host biology in ways that may contribute to cancer risk or cancer prevention. The core scientific aim is to move beyond simply describing the microbiome and instead identify specific microbial metabolites, measure them accurately, and determine what they do at the molecular and cellular level in relation to carcinogenesis and prevention.
A central theme of the FOA is mechanistic clarity. Applicants are expected to characterize microbially generated metabolites derived from diet and connect those metabolites to defined biological effects in host tissues and cells. The announcement highlights several outcome areas of interest: how these metabolites affect cell proliferation and apoptosis (processes tightly linked to tumor formation and suppression), how they influence cytokine production, and how they shape inflammation and broader immune or immunomodulatory responses. In practical terms, the program is looking for studies that can map a chain of evidence from dietary input to microbial transformation to metabolite exposure to host signaling pathways and functional endpoints that matter for cancer etiology or prevention.
The FOA also explicitly encourages human intervention research, not only observational work. A key expectation is that some projects will test dietary components or dietary patterns in people, then track resulting bacterial metabolite production and evaluate whether those metabolites have measurable implications for cancer prevention-relevant biomarkers or pathways. Importantly, the announcement places strong emphasis on inter-individual variability, including variability across racial and ethnic groups. The goal here is to understand why the same diet can yield different microbial metabolic outputs in different people, and whether those differences translate into different levels of benefit or risk. This emphasis ties directly to cancer health disparities: the program is trying to generate evidence that could eventually support more precise dietary recommendations, identifying who is most likely to benefit from a given dietary approach and who might be inadvertently placed at risk.
Because the science crosses several fields, the program is designed to push genuinely interdisciplinary teams. Applications must use a multiple principal investigator model and include investigators with different, complementary expertise. The FOA gives examples of relevant disciplines, including microbiology, nutrition, cancer biology, analytical chemistry, and genetics, reflecting the expectation that teams will combine microbial ecology and function, dietary assessment and intervention design, metabolite identification and quantification, and mechanistic cancer biology. A practical implication is that competitive projects will likely integrate robust metabolomics or targeted analytical chemistry methods with biological assays and, where applicable, well-designed clinical or translational study components.
As a U01 cooperative agreement, the award structure also signals an ongoing partnership with NIH program staff rather than a fully investigator-directed grant with minimal agency involvement. Investigators funded under this FOA are required to attend annual meetings with NIH personnel, which suggests an organized program effort to coordinate progress, share methods and findings, and potentially harmonize approaches across projects. The FOA allows either clinical or preclinical approaches, meaning applicants can propose studies ranging from controlled human dietary interventions to animal models or in vitro systems, as long as the work meaningfully addresses microbial metabolite production from diet and the resulting cancer-relevant biological effects.
From an administrative standpoint, this was a discretionary funding opportunity using the cooperative agreement mechanism, with no cost sharing or matching requirement. It was posted March 15, 2011, with an original and final closing date of November 15, 2012, and an archive date of December 16, 2012. Eligible applicants were broad and included public and private institutions of higher education, nonprofit organizations (including 501(c)(3) and certain non-501(c)(3) entities), small businesses, for-profit organizations other than small businesses, state governments, and additional eligible organizations such as HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian Serving Institutions, U.S. territories or possessions, regional organizations, and certain federal agencies. Foreign organizations were eligible, and foreign components on applications submitted by U.S. organizations were also allowed, reflecting the NIH interest in capturing diverse populations, dietary practices, and microbial-metabolite contexts where scientifically justified.
Overall, the opportunity is aimed at building a clearer, actionable understanding of diet-microbe-host interactions in cancer by identifying the specific microbial metabolites that matter, explaining how they work, and determining how variability across individuals and populations affects both exposure and prevention potential. The long-term payoff the FOA is steering toward is evidence that can support more targeted, biologically grounded dietary guidance for cancer prevention while also addressing population differences that contribute to cancer disparities.
Frequently Asked Questions (FAQs)
What is the title and program number of this funding opportunity?
The opportunity is titled "The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01)" and it is identified as PAR-11-152.
Which NIH institutes are leading this opportunity?
This is a National Institutes of Health (NIH) cooperative agreement led by the National Cancer Institute (NCI) in partnership with the National Center for Complementary and Alternative Medicine (NCCAM).
What is the main scientific focus of this FOA?
The FOA focuses on how gut (and other) microbes transform dietary components into metabolites, and how those microbially produced compounds influence host biology in ways that may contribute to cancer risk or cancer prevention.
How is this FOA different from studies that simply describe the microbiome?
The emphasis is on moving beyond descriptive microbiome profiling to identify specific microbial metabolites, measure them accurately, and determine what they do at the molecular and cellular level in relation to carcinogenesis and prevention.
What kind of evidence chain is the program trying to build?
The program is looking for projects that can connect dietary inputs to microbial transformation, link that to metabolite exposure, and then tie those metabolites to defined host signaling pathways and functional endpoints relevant to cancer etiology or prevention.
What does the FOA mean by emphasizing "mechanistic clarity"?
Applicants are expected to characterize microbially generated metabolites derived from diet and connect them to defined biological effects in host tissues and cells, rather than stopping at correlations.
Which biological outcomes are specifically highlighted as areas of interest?
The FOA highlights effects on cell proliferation and apoptosis, cytokine production, inflammation, and broader immune or immunomodulatory responses, because these processes are tightly tied to tumor formation, suppression, and cancer-related biology.
Are human studies encouraged, or is the focus mainly preclinical?
Human intervention research is explicitly encouraged, not only observational work. At the same time, the FOA allows either clinical or preclinical approaches.
What would a human intervention study look like under this FOA?
The FOA anticipates studies that test dietary components or dietary patterns in people, track resulting bacterial metabolite production, and evaluate whether those metabolites have measurable implications for cancer prevention-relevant biomarkers or pathways.
Does the FOA allow animal models or in vitro studies?
Yes. The FOA allows clinical or preclinical approaches, including animal models or in vitro systems, as long as the work meaningfully addresses microbial metabolite production from diet and the resulting cancer-relevant biological effects.
Why does the FOA emphasize inter-individual variability?
A key theme is that the same diet can yield different microbial metabolic outputs in different people. The FOA aims to understand why that happens and whether those differences translate into different levels of benefit or risk.
How does the FOA connect variability to cancer health disparities?
The FOA places strong emphasis on variability across racial and ethnic groups and links that focus to cancer health disparities, with the goal of generating evidence that could support more precise dietary recommendations based on who benefits, who may be at risk, and why.
What kinds of research disciplines does the FOA expect to be involved?
The FOA is designed for interdisciplinary teams and gives examples including microbiology, nutrition, cancer biology, analytical chemistry, and genetics.
Is a multi-investigator approach required?
Yes. Applications must use a multiple principal investigator (multiple PI) model and include investigators with different, complementary expertise.
What role does metabolite measurement play in competitive applications?
Because the FOA is focused on identifying and accurately measuring microbial metabolites and linking them to mechanisms, competitive projects are expected to integrate robust metabolomics or targeted analytical chemistry methods with relevant biological assays.
What does "U01 cooperative agreement" mean in practice for applicants?
As a U01 cooperative agreement, the award structure signals an ongoing partnership with NIH program staff rather than a fully investigator-directed award with minimal agency involvement.
Are there any collaboration or meeting requirements for awardees?
Yes. Investigators funded under this FOA are required to attend annual meetings with NIH personnel, suggesting coordinated program efforts to share methods and findings and potentially harmonize approaches across projects.
Is cost sharing or matching required?
No. The FOA specifies that there is no cost sharing or matching requirement.
When was this opportunity posted, and what were the closing dates?
It was posted on March 15, 2011. The original and final closing date was November 15, 2012. The archive date was December 16, 2012.
Who was eligible to apply?
Eligible applicants were broad and included public and private institutions of higher education; nonprofit organizations (including 501(c)(3) and certain non-501(c)(3) entities); small businesses; for-profit organizations other than small businesses; state governments; and additional eligible organizations such as HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian Serving Institutions, U.S. territories or possessions, regional organizations, and certain federal agencies.
Are foreign organizations eligible?
Yes. Foreign organizations were eligible, and foreign components on applications submitted by U.S. organizations were also allowed.
Why would the FOA allow foreign organizations or foreign components?
The FOA reflects NIH interest in capturing diverse populations, dietary practices, and microbial-metabolite contexts where scientifically justified.
What is the long-term impact this program is aiming for?
The FOA is steering toward a clearer, actionable understanding of diet-microbe-host interactions in cancer by identifying specific microbial metabolites that matter, explaining how they work, and determining how variability across individuals and populations affects exposure and prevention potential. The long-term goal is evidence that can support more targeted, biologically grounded dietary guidance for cancer prevention while addressing population differences that contribute to cancer disparities.
Browse more opportunities from the same category: Education Health
Next opportunity: Project Leading to Design and Development of Sustainable, Scalable Farmer or Community Seed Storage Models for Vulnerable Populations
Previous opportunity: Cooperative Ecosystem Studies Unit
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 11 152
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 11 152) also looked into and applied for these:
| Funding Opportunity |
|---|
| Basic Cancer Research in Cancer Health Disparities (U01) Apply for PAR 11 156 Funding Number: PAR 11 156 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Collaborative Research in Integrative Cancer Biology and the Tumor Microenvironment (U01) Apply for PAR 11 146 Funding Number: PAR 11 146 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploring Drugs of Abuse and Transgenerational Phenotypes (R01) Apply for RFA DA 12 006 Funding Number: RFA DA 12 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Biomarkers of Infection Associated Cancers (R01) Apply for PA 11 158 Funding Number: PA 11 158 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Biomarkers of Infection Associated Cancers (R21) Apply for PA 11 159 Funding Number: PA 11 159 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R01) Apply for PA 11 160 Funding Number: PA 11 160 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Enhancing Tumoricidal Activity of Natural Killer (NK) Cells by Dietary Components for Cancer Prevention (R21) Apply for PA 11 161 Funding Number: PA 11 161 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R01) Apply for PA 11 162 Funding Number: PA 11 162 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R21) Apply for PA 11 163 Funding Number: PA 11 163 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| The Effect of Racial and Ethnic Discrimination/Bias on Health Care Delivery (R03) Apply for PA 11 164 Funding Number: PA 11 164 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (UM1) Apply for PAR 11 167 Funding Number: PAR 11 167 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition for Competitive Revision Applications to Accelerate and Enhance Collaborative Translational Science (UL1) Apply for RFA RR 11 004 Funding Number: RFA RR 11 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Short Term Research Enhancement Opportunities for Veterinarians (K18) Apply for RFA RR 11 002 Funding Number: RFA RR 11 002 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development Program Projects for Substance Related Disorders (P01) Apply for RFA DA 12 005 Funding Number: RFA DA 12 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Education Program for Laboratory Animal Medicine Veterinarians (R25) Apply for RFA RR 11 003 Funding Number: RFA RR 11 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Systems Biology Approaches in HIV/AIDS and Substance Use (R01) Apply for RFA DA 12 009 Funding Number: RFA DA 12 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $650,000 |
| National Cooperative Drug Discovery and Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (UM1) Apply for PAR 11 206 Funding Number: PAR 11 206 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U19) Apply for PAR 11 207 Funding Number: PAR 11 207 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NLM Express Research Grants in Biomedical Informatics (R01) Apply for PAR 11 208 Funding Number: PAR 11 208 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| NLM Advanced Informatics for Health (R01) Apply for RFA LM 11 002 Funding Number: RFA LM 11 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 11 152", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
